Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience

OBJECTIVES: To report the long-term outcome and toxicity of locoregionally advanced nasopharyngeal carcinoma (LA NPC) treated with nimotuzumab (h-R3) plus intensity-modulated radiotherapy (IMRT) with or without chemotherapy. METHODS: From May 2008 to March 2014, 3022 newly histology-proven, nonmetas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fangzheng, Jiang, Chuner, Ye, Zhimin, Liu, Tongxin, Sun, Quanquan, Yan, Fengqin, Qin, Weifeng, Fu, Zhenfu, Jiang, Yangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723380/
https://www.ncbi.nlm.nih.gov/pubmed/29202278
http://dx.doi.org/10.1016/j.tranon.2017.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723380/
https://www.ncbi.nlm.nih.gov/pubmed/29202278
http://dx.doi.org/10.1016/j.tranon.2017.11.002

Ejemplares similares